Bengamide B
Bengamide B is an alkaloid with anti-tumor and anti-inflammatory activities. Bengamide B reduces the phosphorylation level of IκBα, thereby blocking the activation of NF-κB. Bengamide B inhibits the proliferation of tumor cells. Bengamide B can be used in research related to inflammatory diseases and cancers.
For research use only. We do not sell to patients.
- CAS No.: 104947-69-5
- Formula: C32H58N2O8
- Molecular Weight:598.81
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
IL-6 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HCT-116 | IC50 |
0.002 μM
Compound: 7
|
Cytotoxicity against human HCT116 cells after 48 hrs by SRB assay
Cytotoxicity against human HCT116 cells after 48 hrs by SRB assay
|
[PMID: 22705020] |
| MDA-MB-435 | IC50 |
2 nM
Compound: Bengamide B
|
Cytotoxicity against human MDA-MB-435 cells assessed as reduction in cell viability after 72 hrs by MTS assay
Cytotoxicity against human MDA-MB-435 cells assessed as reduction in cell viability after 72 hrs by MTS assay
|
[PMID: 28185457] |
| RAW264.7 | IC50 |
>50 μM
Compound: 7
|
Cytotoxicity against mouse RAW264.7 cells after 18 hrs by MTT assay
Cytotoxicity against mouse RAW264.7 cells after 18 hrs by MTT assay
|
[PMID: 22705020] |
| RAW264.7 | IC50 |
0.085 μM
Compound: 7
|
Inhibition of LPS-stimulated NFkappaB activation transfected in mouse RAW264.7 cells after 18 hrs by luciferase reporter gene assay
Inhibition of LPS-stimulated NFkappaB activation transfected in mouse RAW264.7 cells after 18 hrs by luciferase reporter gene assay
|
[PMID: 22705020] |
| RAW264.7 | IC50 |
0.5 μM
Compound: 7
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated IL-6 expression up to 10 uM by quantitative RT-PCR analysis
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated IL-6 expression up to 10 uM by quantitative RT-PCR analysis
|
[PMID: 22705020] |
| RAW264.7 | IC50 |
0.5 μM
Compound: 7
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated MCP1 expression up to 10 uM by quantitative RT-PCR analysis
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated MCP1 expression up to 10 uM by quantitative RT-PCR analysis
|
[PMID: 22705020] |
| RAW264.7 | IC50 |
0.5 μM
Compound: 7
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNFalpha expression up to 10 uM by quantitative RT-PCR analysis
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNFalpha expression up to 10 uM by quantitative RT-PCR analysis
|
[PMID: 22705020] |
In Vitro
Bengamide B (18 h) potently inhibits NF-κB activity in RAW264.7 cells with an IC50 of 0.085 μM; it shows no cytotoxicity against RAW264.7 cells at concentrations up to 50 μM; it also potently inhibits the growth of HCT-116 cells with an IC50 of 0.002 μM[1].
Bengamide B (0-10 μM; 4 h) dose-dependently inhibits LPS (HY-D1056)-induced phosphorylation of IκBα in RAW264.7 cells[1].
Bengamide B (0.01-10 μM) dose-dependently inhibits LPS-induced expression of TNFα, IL-6 and MCP-1 in RAW264.7 cells[1].
Bengamide B (3 days) potently inhibits the proliferation of MDA-MB-435 human breast cancer cells in vitro, with an IC50 value of 0.0024 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:murine RAW264.7 macrophage cells
-
Concentration:0, 0.01, 0.1, 1, 10 μM
-
Incubation Time:4 h
-
Result:Dose-dependently reduced the level of phosphorylated IκBα, with greater inhibitory activity observed at higher concentrations.
Maintained consistent total IκBα and β-actin levels across concentrations.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Athymic (nu/nu) nude mice treated MDA-MB-435 cells[2]
-
Dosage:10 µmol/kg; 33 µmol/kg (20 mg/kg)
-
Administration:i.v.; three times per week; 3 weeks
-
Result:Produced a 45% T/C value, with a 0.5% change in average body weight and 0/8 mice dead at 10 µmol/kg.
Produced a 31% T/C value, with a -2.3% change in average body weight and 0/8 mice dead at 33 µmol/kg.
Induced statistically significant tumor growth inhibition at both doses.
Chemical Information
-
CAS No. 104947-69-5
-
Molecular Weight 598.81
-
Formula C32H58N2O8
-
SMILES
CC(C)/C=C/[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC)C(N[C@H]1CC[C@H](OC(CCCCCCCCCCCCC)=O)CN(C)C1=O)=O
-
Structure Classification
-
Initial Source
Jaspis digonoxea
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
[1]. Johnson TA, et al. Myxobacteria versus sponge-derived alkaloids: the bengamide family identified as potent immune modulating agents by scrutiny of LC-MS/ELSD libraries. Bioorg Med Chem. 2012;20(14):4348-4355. [Content Brief]
[2]. Kinder FR Jr, et al. Synthesis and antitumor activity of ester-modified analogues of bengamide B. J Med Chem. 2001;44(22):3692-3699. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)